Solvay Pharmaceuticals, Inc.; Withdrawal of Approval of Two New Drug Applications; Determination That LUVOX (Fluvoxamine Maleate) 25-Milligram, 50-mg, 100-mg, and 150-mg Tablets Was Not Withdrawn for Reasons of Safety or Effectiveness
1 recorded connections shown. Select a record, office or person to follow its source references.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Solvay Pharmaceuticals, Inc.; Withdrawal of Approval of Two New Drug Applications; Determination That LUVOX (Fluvoxamine Maleate) 25-Milligram, 50-mg, 100-mg, and 150-mg Tablets Was Not Withdrawn for Reasons of Safety or Effectiveness
Federal rule or notice · As of Sep 3, 2003
The source record
As of Sep 3, 2003; may be out of date.
- Document number
- 03-22359
- Document type
- Notice
- Title
- Solvay Pharmaceuticals, Inc.; Withdrawal of Approval of Two New Drug Applications; Determination That LUVOX (Fluvoxamine Maleate) 25-Milligram, 50-mg, 100-mg, and 150-mg Tablets Was Not Withdrawn for Reasons of Safety or Effectiveness
- Publication date
- 2003-09-03
- Action
- Notice.
- Html url
- https://www.federalregister.gov/d/03-22359
- Created at
- 2026-09-24T17:36:28.393202
- Updated at
- 2026-09-24T17:36:28.393202
Every link on this map
The same connections as a table, with the reason each one is here.
| Federal rule or notice | What this connects to | Solvay Pharmaceuticals, Inc.; Withdrawal of Approval of Two New Drug Applications; Determination That LUVOX (Fluvoxamine Maleate) 25-Milligram, 50-mg, 100-mg, and 150-mg Tablets Was Not Withdrawn for Reasons of Safety or Effectiveness has a recorded connection to Federal rule or notice. | None |